DCT and melanoma: Moreover, the authors used an aggressive B16F10 melanoma model to demonstrate that mRNA encoding melanoma-related self-antigens, namely tyrosinase-related protein 2 (TRP2) and glycoprotein 100 (gp100), could overcome self-tolerance, thereby resulting in tumor shrinkage, and significantly prolonging the overall survival times of the mice.